GlassScriptPhysician profile
Joseph J Love
NPI 1912988569
$1,667.60
in general payments reported to CMS, 2019-2025
13 companies · $43.56 in 2025
The $43.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $394 · 2021: $131 · 2022: $285 · 2023: $100 · 2024: $79.41 · 2025: $43.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $764.65 | 2019-2020 | |
| Medtronic, INC. | $373.05 | 2021-2023 | Truclear |
| Amgen INC. | $114.48 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $111.79 | 2019 | |
| Minerva Surgical, INC | $57.15 | 2019-2024 | |
| Astellas Pharma US INC | $56.47 | 2023-2025 | Veozah |
| Conmed Corporation | $48.23 | 2022 | |
| Organon LLC | $39.33 | 2022-2023 | |
| Biogen, INC. | $26.52 | 2024 | |
| Hologic Sales and Service, LLC | $24.55 | 2022 | |
| Merck Sharp & Dohme LLC | $21.20 | 2024 | Gardasil 9, Gardasil |
| Meditrina | $18.55 | 2022 | |
| Coopersurgical, INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Love listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.